Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F. · 2013
Read Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. by Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3706898.txt.
Description
Luz-Crawford and colleagues studied how mesenchymal stem cells calm inflammation by reshaping T cell populations. These stem cells are known to suppress the inflammatory Th1 and Th17 cells behind autoimmune disease. The team tested whether they also create regulatory T cells while those inflammatory cells are forming.
Helper T cells were steered toward Th1 or Th17 fates in the presence of the stem cells. A regulatory population marked CD4, CD25, and Foxp3 emerged. It could suppress other T cells. The stem cells did not convert already mature inflammatory cells, though. In a mouse model of multiple sclerosis, early stem cell treatment raised regulatory cells and suppressed Th17 responses, matching the lab finding.
Catalog record
| CREATOR | Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |